This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal My Folders Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Krieg, A. H. Articles by Stalley, P. D. Search for Related Content PubMed PubMed Citation Articles by Krieg, A. H. Articles by Stalley, P. D.

Extracorporeal irradiation for pelvic reconstruction in Ewing’s sarcoma

¹ Orthopaedic Department University Children’s Hospital (UKBB), P. O. Box, Römergasse 8, 4005 Basel, Switzerland.
² Orthopaedic Department Royal Prince Alfred Hospital, Missenden Road, Camperdown, New South Wales, Australia.

Correspondence should be sent to Dr A. H. Krieg; e-mail: andreas.krieg{at}ukbb.ch

We review the treatment of pelvic Ewing’s sarcoma by the implantation of extracorporeally-irradiated (ECI) autografts and compare the outcome with that of other reported methods.

We treated 13 patients with ECI autografts between 1994 and 2004. There were seven males and six females with a median age of 15.7 years (interquartile range (IQR) 12.2 to 21.7). At a median follow-up of five years (IQR 1.8 to 7.4), the disease-free survival was 69% overall, and 75% if one patient with local recurrence after initial treatment elsewhere was excluded. Four patients died from distant metastases at a mean of 17 months (13 to 23). There were three complications which required operative intervention; one was a deep infection which required removal of the graft. The functional results gave a mean Musculoskeletal Tumor Society score of 85% (60% to 97%), a mean Toronto extremity salvage score of 86% (69% to 100%) and a mean Harris hip score of 92 (67 to 100).

We conclude that ECI grafting is a suitable form of treatment for localised and resectable pelvic Ewing’s sarcoma.